跳至主要内容
临床试验/NL-OMON54180
NL-OMON54180招募中不适用

Peri-operative Magnesium infusion to Prevent Atrial fibrillation Evaluated. - POMPAE trial

HagaZiekenhuis0 个研究点目标入组 530 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
530

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Elective cardiac surgery (valve surgery and/or CABG)
  • - 18 years and above

排除标准

  • - History of atrial fibrillation (AF) or atrial flutter
  • - Concomitant rhythm associated procedures (MAZE (surgical ablation)/PVI
  • (pulmonary vein isolation))
  • - Pre-existing severe renal impairment (eGFR<30 ml/min) or development of
  • oliguria post-surgery (<200 ml in previous 6 hours) and/or rise in creatinine
  • with eGFR <30 ml/min)
  • - Significant hypotension persisting for 1 hour or longer (Noradrenaline >0.1
  • mcg/kg/min)
  • - Development of third-degree heart block during index admission or
  • pre-existing 3rd degree heart block without pacemaker presence.

研究者

相似试验

Peri-operative Magnesium infusion to Prevent Atrial... | 临床试验